Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
Send Cancel

Pirbright research to make vaccines more accessible
Pirbright research could boost vaccine yields by up to tenfold. 
Scientists to use gene-editing technology to remove major barrier to viral replication

Livestock vaccines may soon be more accessible and affordable thanks to funding from the Livestock Vaccine Innovation Fund.

The funding has been awarded to the Pirbright Research Institute to allow previous immune response research to continue. The research will involve using gene-editing technology to remove chiFITM proteins in chicken cells - one of the major barriers to viral replication - and could boost vaccine yields by up to tenfold.

Dr Mark Fife from Pirbright's Genetics and Genomics Group, which is leading the research, explains: “Many vaccines for both animal and human, are produced by going a weakened form of the virus in chicken eggs or cells, which are then extracted for use.

“Although chiFITM may help protect chickens from viral infection, the protein actually hinders vaccine productions, as it prevents the weakened virus from replicating at high levels and reduces the amount of vaccine that can be made.

"Our new research will involve using a gene-editing system called CRISPR/Cas9 to remove the chIFITM genes in chicken cells, therefore overcoming one of the barriers for viral replication, and boosting the levels of vaccine virus produced.”

This boost to vaccine production will make vaccines cheaper to produce and more accessible to livestock owners in developing nations. The scientists will first focus on increasing flu vaccine yields, but the method could also be applied to multiple livestock diseases and potentially human diseases too.

When the researchers have piloted the technique, they will work with commercial partners Horizon Discovery Group plc to bring this new technology to market. It is hoped the technology will commercially available as soon as 2021. 

Become a member or log in to add this story to your CPD history

Wildlife presenter to deliver keynote speech at BVA Congress

News Story 1
 The BVA has confirmed wildlife presenter Mike Dilger will deliver the keynote speech at this yearís congress. Mike is known as ĎBritainís most diseased maní, having contracted a number of exotic diseases on his travels, including malaria, bilharzia and leishmaniasis. His talk, ĎMy diseases and other animalsí, promises to be an amusing and inspiring lecture on his travels in the tropics and his thoughts on how the mass media is influencing human engagement with wildlife and nature. The lecture will take place at 1pm on 16 November, in the BVA Congress Theatre at Londonís ExCeL. 

Click here for more...
News Shorts
Vet school runs event for aspiring vets and nurses

Bristol Veterinary School is hosting an event for aspiring vets and vet nurses, to allow them to experience life as a student and find out what itís like to work in veterinary medicine. The one-day event, called VetQuest, will be held at the Langford Campus and includes a tour, talks on admissions and work experience, and the chance to take part in practical sessions. Taking place on Saturday 27 October, the event is primarily aimed at 11-12 year olds and costs £50, including lunch. There are a limited number of subsidised tickets for £10. To book, visit VetQuest 2018